Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Fortrea (FTRE)

Fortrea Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FTRE
DateTimeSourceHeadlineSymbolCompany
16/05/202421:05GlobeNewswire Inc.Fortrea Appoints Machelle Sanders to Board of DirectorsNASDAQ:FTREFortrea Holdings Inc
13/05/202412:10IH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:FTREFortrea Holdings Inc
13/05/202411:30GlobeNewswire Inc.Fortrea Reports First Quarter 2024 ResultsNASDAQ:FTREFortrea Holdings Inc
06/05/202413:22GlobeNewswire Inc.Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
11/04/202412:00GlobeNewswire Inc.Fortrea Announces Date for First Quarter 2024 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
11/03/202410:30GlobeNewswire Inc.Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 GuidanceNASDAQ:FTREFortrea Holdings Inc
11/03/202410:30GlobeNewswire Inc.Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersNASDAQ:FTREFortrea Holdings Inc
20/02/202421:05GlobeNewswire Inc.Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRxâ„¢ ExpansionNASDAQ:FTREFortrea Holdings Inc
20/02/202412:00GlobeNewswire Inc.Fortrea to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
29/01/202412:00GlobeNewswire Inc.Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
09/01/202421:22GlobeNewswire Inc.Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial ExperienceNASDAQ:FTREFortrea Holdings Inc
08/01/202412:00GlobeNewswire Inc.Fortrea Previews J.P. Morgan Healthcare Conference UpdatesNASDAQ:FTREFortrea Holdings Inc
04/01/202413:00PR Newswire (US)FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDERNASDAQ:FTREFortrea Holdings Inc
02/01/202412:00GlobeNewswire Inc.Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
13/12/202312:00GlobeNewswire Inc.Fortrea Convenes New Site Advisory BoardNASDAQ:FTREFortrea Holdings Inc
20/11/202312:00GlobeNewswire Inc.Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical TrialsNASDAQ:FTREFortrea Holdings Inc
13/11/202311:30GlobeNewswire Inc.Fortrea Reports Third Quarter 2023 ResultsNASDAQ:FTREFortrea Holdings Inc
02/11/202311:00GlobeNewswire Inc.Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.NASDAQ:FTREFortrea Holdings Inc
17/10/202314:05Business WireStarboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor SummitNASDAQ:FTREFortrea Holdings Inc
13/10/202312:00GlobeNewswire Inc.Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting TeamNASDAQ:FTREFortrea Holdings Inc
11/10/202312:00GlobeNewswire Inc.Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
10/10/202312:00GlobeNewswire Inc.Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopicsNASDAQ:FTREFortrea Holdings Inc
06/09/202316:00GlobeNewswire Inc.Fortrea to Present at the Baird 2023 Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
06/09/202316:00GlobeNewswire Inc.Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:FTREFortrea Holdings Inc
14/08/202312:00GlobeNewswire Inc.Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 GuidanceNASDAQ:FTREFortrea Holdings Inc
20/07/202312:00GlobeNewswire Inc.Fortrea Announces Date for Second Quarter 2023 Financial Results and Conference CallNASDAQ:FTREFortrea Holdings Inc
18/07/202312:40GlobeNewswire Inc.Incannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep ApnoeaNASDAQ:FTREFortrea Holdings Inc
03/07/202312:05GlobeNewswire Inc.Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients FasterNASDAQ:FTREFortrea Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:FTRE